Zoom Links

Main Session: Note that  you will need to register for the session with your name and email..  This is how we will take attendance.   This will be in webinar format.

Lunch Session: Horizon will be presenting a lunch time product theater on Understanding Thyroid Eye Disease (TED): A Serious, Debilitating, Autoimmune Eye Disease from 12:20-12:50pm during the break. The link to atend this meeting is






    PDF's of the presentations can be found here:


    Password NETC


    Speaker Bios

     PDF icon NETC23 Speaker Bios for web.pdf


    Continuing Education Information

    PDF icon NETC23 Front Matter FINAL.pdf


    How to Claim Your Credit/Certificate  

    Certificates are issued online post meeting after completion of the evaluation.

    1. Go to https://cme.bu.edu/NETC23 after the meeting has ended.
    2. Login with the username/password you used to register for the conference
    3. This will take you back to the conference home page
    4. Click “Take Course”
    5. Follow instructions/steps for completing the evaluation and claiming credit. Note that you will be asked to select if you attended in person or virtually.
    6. If you have trouble, please contact the office at 617-358-5005 or cme@bu.edu


    During the meeting, please put your questions in the webinar Q&A or chat.  Our moderators will be monitoring these channels.

    For technical assistance, please reach out in chat or call  617-358-5005.



    This activity is provided in part by support from:

    Platinum Support

    • Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.

    Gold Support

    • Eisai Inc. is a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases).